Medox® is developed, processed and packaged at the Biolink Group’s own processing factory in Sandnes, Norway. This means that the extremely stringent quality requirements of the pharmaceutical part of the company have been transferred to commercial production of the professional dietary supplement under full control and with no exceptions to the highest
standards of quality.

Medox® consists of a natural optimized anthocyanin complex (MP865®), concentrated on the molecules Cyanidin-3-Glucopyranoside and Delphinidin-3-Glucopyranoside. In the patented manufacturing process, these specific molecules are collected from bilberries and blackcurrants.

In order to manufacture this unique professional dietary supplement, MP865®, the Biolink Group has developed a patented, high-tech, membrane-chromatographic, nitrogen based process. This extremely high-quality process is necessary to ensure that the anthocyanin product possesses all its potential health effects when finally consumed by man.

Unlike common blueberry pills, Medox® is very well clinically documented. The clinical studies were performed at independent international university hospitals and universities. Studies have taken place and are taking place in Norway, EU, USA and Asia.
Since 2001, Medox® has been concentrated on the Norwegian domestic market. Sales in Sweden through health care professionals are starting up in 2007. In the first half of 2007, Medox® was approved by FDA for sale in USA.

Chapter from article written by Professor Micheal C Altman, CN,RH(AHG), Ajunct Professor  Nutrition, Southern Oregon University, NorCal

Anthocyanins
The leaves of blueberry are not the only useful part. The pigments that come from blueberries (bilberries), black currants and other berries, as well as the skins of some vegetables anthocyanins have marked therapeutic effects. I recommend a highly concentrated 80 mg anthocyanin capsule (MEDOX Optimal) for any client with diabetes to slow the multisystemic degeneration associated with the condition.

MEDOX is a veg-encapsulated anthocyanin extract from wild Norwegian bilberries (Vaccinium myrtillus) and black currants (Ribes nigrum). MEDOX is produced in Norway by MedPalett Pharmaceuticals and the Biolink Group. Consumed in Norway and throughout the European Union as a phytoceutical sold in pharmacies and doctors offices, MEDOX is now a powerful botanical ally for Americans. Existing in a phytochemical color spectrum that moves through red to purple and deep blue, the pigments in MEDOX contain unique biological activity in humans. Few, if any other, products on the worldwide market have the intensity of color that indicates such a threshold of powerful and concentrated anthocyanins.

A unique and patented technology provides for large amounts (80 mg) of anthocyanins per capsule. The capsules are processed using chromatographic membrane technology. The special processing allows free and complete anthocyanins to quickly penetrate plasma at an affordable cost per milligram yielding sustained levels in connective tissue. The absorption and beneficial effects of MEDOX have been clinically documented at Scandinavian university hospitals and clinics.

Anthocyanins have proven efficacy for a range of modern medical problems, especially those related to the cardiovascular system, nervous system and eyes. MP865, the anthocyanin blend found in MEDOX, is also known to regulate healthy cell proliferation, blocking progression of cancer at various stages. Anthocyanins have demonstrated to be powerfully anti-leukemic. Preventing invasion of cancer by reinforcing the strength of collagen and blood vessels, anthocyanins from MEDOX induce apoptosis, organized cancer cell death. They also discourage angiogenesis and inflammation, major factors enabling cancer to spread. In this sense, MP865 from MEDOX is carcinostatic and anti-metastatic. Studies have been/are being conducted on anthocyanins and MEDOX for prostate, lung, brain, gastric, esophageal and colon cancer, though it may prove to be effective on a wide range of cancers.

Anthocyanins from bilberry are perhaps best known for the roles they play in protecting the eyes from injury related to oxidative stress and poor capillary microcirculation, such as macular degeneration and cataracts. Bilberry anthocyanins improve night vision and retinopathies. Mitigating and reversing complications related to diabetes and insulin resistance is a unique domain of anthocyanins in that they protect the blood vessels, eyes and kidneys. Furthermore, studies from Ulleval University Hospital in Norway indicate that 2 caps daily of MEDOX Optimal lowered C-reactive protein (a marker of inflammation) by 28% after two weeks. Though this study was performed on a small sample size, compare the results to 17% reduction for statin drugs, which bear considerable side effects.

Other as yet unreleased studies from Ulleval show significant decreases in resting heart rate and blood pressure after short-term MEDOX therapy. Anthocyanins (from MEDOX) are safe and effective and have no known side effects or contra-indications. In practice, I have clients pair MEDOX with blueberries (and other berries), which contain the soluble fiber, caloric and other nutritive components. In the colder months, I also recommend blueberry solid extract, a delicious concentrated paste made by Herbalist and Alchemist that clients can spread or mix in smoothies.

Anthocyanins are efficient atherosclerosis fighters through their ability to counter oxidants. Studies have shown anthocyanins to lower oxidative LDL levels, which are significant risk factors for cardiovascular diseases. Anthocyanins have a proven ability to protect the integrity of the endothelial cells lining the blood vessels. They regulate nitrogen oxide synthesis, offering further cardiovascular and erectile support. The resulting effect of taking MEDOX anthocyanins is smoother, better dilated, more flexible and stronger blood vessels.

In theory, MEDOX and anthocyanins paired with magnesium supplementation should greatly reduce risk of sudden cardiac death and stroke, thus I often recommend them in combination. The preceding interrelationships of anthocyanins’ benefits offer promise for improvement in the big picture of the diabetic tangle.

Conclusion
Patients and practitioners are looking for new ways to manage various chronic diseases, including those related to insulin resistance and diabetes. A multi-faceted approach must ultimately be part of diabetes treatment. We can start with education for prevention, diet, lifestyle modification and exercise. Supportive nutritional and botanical therapies can also play vital roles before reliance on multiple medications (polypharmacy) and more costly interventions.

About the Author:

Michael C. Altman, CN, RH (AHG)
Adjunct Professor, Nutrition, Southern Oregon University, College of the Siskiyous, NorCal
Certified Nutritionist, Registered Herbalist (American Herbalists Guild)

ABOUT THE AUTHOR
Michael is a certified nutritionist, registered herbalist and nationally registered emergency medical technician (NREMT). His interest in the medicinal and food value of wild plants brought him to a greater understanding of and interest in nutrition and the link between our health and that of the environment. Michael works at the Centre for Natural Healing in Ashland, OR and Norwalk, CT, and Ventana Wellness and Rogue EMC-Endocrinology and Metabolic Clinic in Medford, OR. He also teaches nutrition “three ways.” He offers a live, in-person class at Southern Oregon University and teaches a distance teleconference class for College of the Siskiyous, NorCal, from SOU’s Ashland campus. Lastly, he teaches an internet class for College of the Siskiyous.